DNAJC12 and dopa-responsive nonprogressive parkinsonism-Reference-Cited by-同舟云学术

DNAJC12 and dopa-responsive nonprogressive parkinsonism

Published:2017-10 Issue:4 Volume:82 Page:640-646
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Straniero Letizia¹^ORCID,Guella Ilaria²,Cilia Roberto³,Parkkinen Laura⁴,Rimoldi Valeria¹⁵,Young Alexander²,Asselta Rosanna¹⁵^ORCID,Soldà Giulia¹⁵^ORCID,Sossi Vesna⁶,Stoessl A. Jon⁶,Priori Alberto⁷,Nishioka Kenya⁸,Hattori Nobutaka⁸,Follett Jordan²,Rajput Alex⁹,Blau Nenad¹⁰,Pezzoli Gianni³,Farrer Matthew J.²,Goldwurm Stefano³^ORCID,Rajput Ali H.⁹,Duga Stefano¹⁵^ORCID

Affiliation:

1. Department of Biomedical Sciences; Humanitas University; Pieve Emanuele Milan Italy

2. Centre for Applied Neurogenetics; University of British Columbia; Vancouver BC Canada

3. Parkinson Institute, ASST “Gaetano Pini-CTO”; Milan Italy

4. Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre; University of Oxford; Oxford United Kingdom

5. Humanitas Clinical and Research Center; Rozzano Milan Italy

6. Pacific Parkinson's Research Centre & Djavad Mowafaghian Centre for Brain Health; University of British Columbia; Vancouver BC Canada

7. “Aldo Ravelli” Research Center for Neurotechnology and Experimental Brain Therapeutics; Department of Health Sciences, University of Milan & ASST Santi Paolo e Carlo; Milan Italy

8. Department of Neurology; Juntendo University School of Medicine; Tokyo Japan

9. Division of Neurology, Saskatchewan Movement Disorders Program; University of Saskatchewan, Royal University Hospital; Saskatoon SK Canada

10. Dietmar-Hopp-Metabolic Center, Department of General Pediatrics; University Hospital; Heidelberg Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference20 articles.

1. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability;Anikster;Am J Hum Genet,2017

2. The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism;Pons;J Inherit Metab Dis,2009

3. Monoamine neurotransmitter disorders-clinical advances and future perspectives;Ng;Nat Rev Neurol,2015

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Dnajc12 knockout mice, a model of hypodopaminergia;2024-07-10

2. Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms;Biochemical Society Transactions;2024-05-30

3. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT;Redox Biology;2024-04

4. A Case of DNAJC12-Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early Detection;International Journal of Neonatal Screening;2024-01-17

5. Mouse models for inherited monoamine neurotransmitter disorders;Journal of Inherited Metabolic Disease;2024-01-02